Physician

Michelle Lynn Young, MD, FRCSC

According to 2025 Medicare claims, Michelle Young, MD, FRCSC (NPI: 1932122264) practices ophthalmology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is RETINA CENTER OF VERMONT, INC (NPI: 1215068770; TIN: 203110154) and primary practice location at 05403-7359.

Young's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 911 traditional Medicare patients, billed 12,020 HCPCS/CPT codes, and received $2,349,249 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 190 prescription claims across 59 beneficiaries totaling $6,964 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,068,963 to $2,349,249. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,450 and ending at $6,964. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	952	7,985	$1,068,963
2016	998	8,288	$882,768
2017	1,125	8,651	$1,040,531
2018	1,168	9,822	$1,110,163
2019	1,224	10,461	$1,459,602
2020	1,154	9,937	$1,498,873
2021	1,236	10,229	$1,741,200
2022	1,202	10,466	$2,026,337
2023	900	9,946	$2,149,787
2024	911	12,020	$2,349,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	131	$9,450
2016	40	143	$11,994
2017	34	114	$5,903
2018	48	160	$8,961
2019	51	138	$5,552
2020	45	150	$5,762
2021	59	237	$12,879
2022	103	345	$19,680
2023	79	259	$12,534
2024	59	190	$6,964

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	239	2,270	$658
92235	Exam of retinal blood vessels using a special camera after injection of a dye	192	256	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	676	1,389	$85
67028	Injection of drug into eye	349	1,748	$80
92134	Imaging of retina	805	1,678	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	64	1,304	$1,877
Atropine Sulfate	Atropine Sulfate	29	967	$778
Ofloxacin	Ofloxacin	34	730	$353
Latanoprost	Latanoprost	20	508	$28

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michelle Lynn Young, MD, FRCSC?

Tedicare shows public-source Medicare data for Michelle Lynn Young, MD, FRCSC (NPI 1932122264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Lynn Young, MD, FRCSC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michelle Lynn Young, MD, FRCSC?

Michelle Lynn Young, MD, FRCSC is linked to RETINA CENTER OF VERMONT, INC (billing NPI 1215068770) in the available physician profile data.

Does Michelle Lynn Young, MD, FRCSC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.